Literature DB >> 24362764

Axonal transport of neprilysin in rat sciatic nerves.

Genki Ohkushi1, Noriko Suzuki, Shigeki Kobayashi, Toshiyuki Chikuma.   

Abstract

Axonal transport of neprilysin, a putative neuropeptide degrading-enzyme, was examined in the proximal, middle, and distal segments of rat sciatic nerves using a double ligation technique. Neprilysin activity was significantly increased not only in the proximal segment but also in the distal segment 12-120 h after ligation, and the maximal neprilysin activity was found in the proximal and distal segments at 96 and 72 h, respectively. Western blot analysis of neprilysin showed that its immunoreactivities in the proximal and distal segments were 2.8- and 2.4-fold higher than that in the middle segment, indicating that neprilysin is transported by anterograde and retrograde axonal flow. These observations suggest that neprilysin may be involved in the metabolism of neuropeptides in nerve terminals or synaptic clefts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24362764     DOI: 10.1007/s12031-013-0202-6

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  31 in total

1.  Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases.

Authors:  K Shirotani; S Tsubuki; N Iwata; Y Takaki; W Harigaya; K Maruyama; S Kiryu-Seo; H Kiyama; H Iwata; T Tomita; T Iwatsubo; T C Saido
Journal:  J Biol Chem       Date:  2001-03-06       Impact factor: 5.157

Review 2.  Inactivation and metabolism of neuropeptides.

Authors:  J F McKelvy; S Blumberg
Journal:  Annu Rev Neurosci       Date:  1986       Impact factor: 12.449

3.  Immunohistochemical study of cholecystokinin peptide in rat spinal motoneurons.

Authors:  R Cortés; K Aman; U Arvidsson; L Terenius; P Frey; J F Rehfeld; J H Walsh; T Hökfelt
Journal:  Synapse       Date:  1991-10       Impact factor: 2.562

4.  Axonal transports of Boc-Gly-Arg-Arg-MCA hydrolysing enzyme in rat sciatic nerves.

Authors:  T Kato; R Yajima; N Sato; K Takahashi; C Shimizu; T Chikuma
Journal:  Neurochem Int       Date:  1998-02       Impact factor: 3.921

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease.

Authors:  Sadim Jawhar; Oliver Wirths; Thomas A Bayer
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

7.  Anterograde axonal transport of peptidylglycine alpha-amidating monooxygenase in rat sciatic nerves.

Authors:  K Tozawa; E Arakawa; T Chikuma; Y Oh-hashi; R Yajima; K Takeda; H Shinozaki; T Kato
Journal:  J Neurochem       Date:  1990-09       Impact factor: 5.372

8.  Purification of endopeptidase-24.11 ('enkephalinase') from pig brain by immunoadsorbent chromatography.

Authors:  J M Relton; N S Gee; R Matsas; A J Turner; A J Kenny
Journal:  Biochem J       Date:  1983-12-01       Impact factor: 3.857

Review 9.  Take five--BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation.

Authors:  Christian Haass
Journal:  EMBO J       Date:  2004-01-29       Impact factor: 11.598

10.  Alzheimer's Aβ peptides with disease-associated N-terminal modifications: influence of isomerisation, truncation and mutation on Cu2+ coordination.

Authors:  Simon C Drew; Colin L Masters; Kevin J Barnham
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

View more
  3 in total

Review 1.  Clinical genetics of Charcot-Marie-Tooth disease.

Authors:  Yujiro Higuchi; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2022-03-18       Impact factor: 3.755

2.  MME mutation in dominant spinocerebellar ataxia with neuropathy (SCA43).

Authors:  Chantal Depondt; Simona Donatello; Myriam Rai; François Charles Wang; Mario Manto; Nicolas Simonis; Massimo Pandolfo
Journal:  Neurol Genet       Date:  2016-08-18

3.  Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2.

Authors:  Yujiro Higuchi; Akihiro Hashiguchi; Junhui Yuan; Akiko Yoshimura; Jun Mitsui; Hiroyuki Ishiura; Masaki Tanaka; Satoshi Ishihara; Hajime Tanabe; Satoshi Nozuma; Yuji Okamoto; Eiji Matsuura; Ryuichi Ohkubo; Saeko Inamizu; Wataru Shiraishi; Ryo Yamasaki; Yasumasa Ohyagi; Jun-ichi Kira; Yasushi Oya; Hayato Yabe; Noriko Nishikawa; Shinsuke Tobisawa; Nozomu Matsuda; Masayuki Masuda; Chiharu Kugimoto; Kazuhiro Fukushima; Satoshi Yano; Jun Yoshimura; Koichiro Doi; Masanori Nakagawa; Shinichi Morishita; Shoji Tsuji; Hiroshi Takashima
Journal:  Ann Neurol       Date:  2016-03-17       Impact factor: 10.422

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.